• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Peer Review, Editorial Process Yield Improvements in RCT Abstracts

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 3, 2025.

WEDNESDAY, Sept. 3, 2025 -- Peer review and the editorial process yield frequent improvements in research abstracts of randomized clinical trial (RCT) reports, according to a research letter published online Sept. 2 in the Annals of Internal Medicine.

Christos P. Kotanidis, M.D., D.Phil., from Brigham and Women's Hospital in Boston, and colleagues assessed abstracts of all RCT reports submitted to the New England Journal of Medicine in 2022 to examine how the quality of abstracts changes between submission and publication.

Of the submissions to NEJM in 2022 that were matched to PubMed records, 496 were RCTs: 156 were published in the NEJM, and 340 were rejected and published in 128 other journals. The researchers found that published abstracts improved in 0.9 domains on average; 59 percent of abstracts improved. The most frequently modified domain was the conclusion (44.2 percent). Overall, 72.1 percent of the 229 abstracts published in the five general medicine journals with a journal impact factor above 50 improved in at least one domain compared with 48.3 percent of the 267 abstracts published in other journals. This difference was consistent across domains of the abstract, with changes in the conclusion being the most different (48 versus 27 percent). Substantive improvements were seen in more than half of the abstracts published in non-open access journals (61.5 percent) compared with 39.2 percent of abstracts published in open access journals.

"Our results highlight the substantial revisions and improvements that occur between submission and publication, supporting the value of editorial oversight in ensuring research is communicated with accuracy and integrity," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted September 2025

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.